Quadrature Capital Ltd raised its stake in PetMed Express, Inc. (NASDAQ:PETS – Free Report) by 127.2% in the 3rd quarter, Holdings Channel reports. The fund now owns 29,597 shares of the company's stock after purchasing an additional 16,573 shares during the quarter. Quadrature Capital Ltd's holdings in PetMed Express were worth $303,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently changed their positions in the stock. Schonfeld Strategic Advisors LLC increased its holdings in shares of PetMed Express by 20.5% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 54,900 shares of the company's stock valued at $563,000 after acquiring an additional 9,331 shares during the last quarter. Ancora Advisors LLC bought a new position in PetMed Express in the 3rd quarter valued at approximately $958,000. Trexquant Investment LP bought a new position in PetMed Express in the 3rd quarter valued at approximately $554,000. Numerai GP LLC bought a new position in PetMed Express in the 3rd quarter valued at approximately $216,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of PetMed Express by 13.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 368,573 shares of the company's stock valued at $3,778,000 after purchasing an additional 44,846 shares during the last quarter. Institutional investors own 74.99% of the company's stock.
Analyst upgrades and downgrades
Separately, Morgan Stanley lowered their target price on shares of PetMed Express from $7.00 to $6.50 and gave the company an “underweight” rating in a report on Thursday, November 16th.
Get the latest analysis with PetMed Express
PetMed Express trades up 0.2%
NASDAQ PETS stock opened Friday at $5.02. The company's 50 day simple moving average is $6.15 and its 200 day simple moving average is $8.05. PetMed Express, Inc. has a 1 year low of $4.84 and a 1 year high of $18.39.
Petmed Express Profile
(Free report)
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company sells prescription and nonprescription pet medications, health products, and other supplies for dogs, cats, and horses. We offer non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products and consumables. Also includes prescription medications such as heartworm preventatives, flea and tick preventives, arthritis, dermatitis, thyroid, diabetes, pain relievers, heart/blood pressure, and other specialty medications or generic alternatives.
Featured articles
Curious if other hedge funds hold PETS? Visit HoldingsChannel.com to get the latest 13F filing and insider transactions for PetMed Express, Inc. (NASDAQ:PETS – Free Report).
Receive daily PetMed Express news and reviews – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for PetMed Express and related companies in MarketBeat.com's free daily email newsletter.
